AzTrials
AzTrials

Injection PainPhase 4NCT02285972

Efficacy of Intravenous Dexketoprofen and Tenoxicam on Propofol Associated Injection Pain

A Phase 4 study testing saline, dexketoprofen and tenoxicam in people with Injection Pain, run by Ordu University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Propofol remains the most common drug for induction of general anaesthesia, although it causes considerable pain or discomfort on injection. Anesthesia providers have attempted a large number of remedies to prevent this pain on injection. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Injection Pain
What is being tested?
saline, dexketoprofen and tenoxicam
Type of treatment
Injection or infusion
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
118 participants
Where
1 siteTurkey (Türkiye)
Study dates
Nov 2014to Apr 2015
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • American Society of Anesthesiologists (ASA) physical status 1 and 2
  • 18 - 65 years
  • general anesthesia scheduled for elective surgery

Who cannot join

  • age < 18 years, > 65 years
  • pregnancy
  • patients requiring a rapid sequence induction
  • refusal to participate and patients already participating in another study
  • allergy to study drugs
  • communication difficulty
Show all 11Show fewer
  • psychiatric and neurolojic disorders
  • use of analgesics or sedative drugs within 24 hours before surgery.
  • emergency surgery
  • history of drug or alcohol abuse
  • ASA 3 and above

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Anesthesiology and Reanimation Dept. Ordu University Training and Research Hospital

    Altinordu, Ordu, 52100

Other trials in Turkey (Türkiye)

About this study

Propofol remains the most common drug for induction of general anaesthesia, although it causes considerable pain or discomfort on injection. Anesthesia providers have attempted a large number of remedies to prevent this pain on injection. Previously explored ideas include injecting propofol into larger veins, warming of the hand with hot packs, and intravenous pretreatment with numerous other medications. No studies to date have looked at the dexketoprofen and tenoxicam for the pretreatment of pain on injection caused by propofol. The investigators propose studying the use of dexketoprofen and tenoxicam for pretreatment of propofol related pain on injection.

Conditions
Injection Pain
Being tested
saline, dexketoprofen, tenoxicam

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • salineDrug

    Also called serum physiologic

    before the anesthesia induction, 2mL saline iv injection

  • dexketoprofenDrug

    Also called Arveles, Leodex

    before the anesthesia induction, 50 mg (2mL) iv dexketoprofen

  • tenoxicamDrug

    Also called Oksamen-L, Tilcotil

    before the anesthesia induction, 20 mg (2mL) iv tenoxicam

Study groups in NCT02285972
Study groupRoleWhat they receive
salinePlacebo comparatorNot described
Receives: Drug: saline
dexketoprofenActive comparatorNot described
Receives: Drug: dexketoprofen
tenoxicamActive comparatorNot described
Receives: Drug: tenoxicam

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Verbal Pain Score

    Measured: Approximately one minute following administration of propofol.

  2. Facial Pain Score

    Measured: Approximately one minute following administration of propofol.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Nov 2014 (estimated)
  2. Study startNov 2014
  3. Primary completionApr 2015
  4. Study completionApr 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
118 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02285972
Sponsor's protocol ID
Odu-5
Status last verified
Nov 2014
First submitted
1 Nov 2014
Last updated
21 Apr 2015
Results posted
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing saline, dexketoprofen and tenoxicam in people with Injection Pain, run by Ordu University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Apr 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Verbal Pain Score (time frame: Approximately one minute following administration of propofol.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Apr 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in